Recent studies have shown that N-acetyltransferase 10 (NAT10) and its mediated RNA N4-acetylcytidine (ac4C) modification are significantly upregulated in clear cell renal cell carcinoma (ccRCC) and are associated with poor prognosis in patients. Here, NAT10 is linked to nonpapillary renal cell carcinoma.